Difference between revisions of "Advanced Tissue Sciences"
Jump to navigation
Jump to search
WikiModEn2 (talk | contribs) (Insert SEEALSO section.) |
m (USSC, pages) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> | <!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> | ||
| − | '''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested [[foreskin | + | '''Advanced Tissue Sciences''' is a corporation based in La Jolla, {{USSC|CA}}. They are the makers of [[Dermagraft-TC]], which is an artifical [[skin]] created from harvested [[foreskin]]s from infant [[circumcision]].<ref name='Advanced Biohealing, 2010'>{{REFweb |
|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
|last= | |last= | ||
| Line 32: | Line 32: | ||
Dermagraft-TC is FDA approved,<ref>{{REFweb | Dermagraft-TC is FDA approved,<ref>{{REFweb | ||
| − | |quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | + | |quote=Dermagraft-TC is the first human, fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. |
|last= | |last= | ||
|first= | |first= | ||
| Line 49: | Line 49: | ||
|url=http://www.highbeam.com/doc/1G1-47248437.html | |url=http://www.highbeam.com/doc/1G1-47248437.html | ||
|accessdate=2011-05-07 | |accessdate=2011-05-07 | ||
| − | }}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref> | + | }}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref> |
Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.<ref>{{REFbook | Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.<ref>{{REFbook | ||
|last=Pitta | |last=Pitta | ||
|first=Julie | |first=Julie | ||
| + | |init=J | ||
|date=1993-05-10 | |date=1993-05-10 | ||
|title=Biosynthetics | |title=Biosynthetics | ||
| Line 61: | Line 62: | ||
|volume= | |volume= | ||
|chapter= | |chapter= | ||
| − | |pages=170- | + | |pages=170-1 |
|location= | |location= | ||
|publisher=Forbes | |publisher=Forbes | ||
| Line 72: | Line 73: | ||
|title=Biotech's Big Discovery | |title=Biotech's Big Discovery | ||
|last=Hall | |last=Hall | ||
| − | | | + | |init=CT |
|journal=San Francisco Chronicle | |journal=San Francisco Chronicle | ||
|date=1996-10-25 | |date=1996-10-25 | ||
| − | |pages=E1 | + | |pages=E1+E4 |
}}</ref> | }}</ref> | ||
{{SEEALSO}} | {{SEEALSO}} | ||
| − | |||
* [[Gail K. Naughton]] | * [[Gail K. Naughton]] | ||
Latest revision as of 15:23, 28 March 2022
Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an artifical skin created from harvested foreskins from infant circumcision.[1] They are also the makers of NouriCel, another product made from harvested foreskins,[2] and one of the main ingredients of SkinMedica's TNS Recovery Complex product.[3]
Earnings
Dermagraft-TC is FDA approved,[4][5] and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.[6]
Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.[7]
In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.[8]
See also
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
The Foreskin Mafia
, Acroposthion.com. Retrieved 6 March 2011.
Quote:TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
- ↑ (12 February 2002).
SkinMedica Introduces TNS Recovery Complex
, SkinMedica. Retrieved 6 March 2011.
Quote:TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
- ↑ (2011).
Dermagraft-TC: General Information: Advanced Tissue Sciences
, MediLexicon International Ltd. Retrieved 7 May 2011.
Quote:Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑ (28 March 1997).
Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
, HighBeam Research. Retrieved 7 May 2011.
Quote:the Food and Drug Administration has approved Dermagraft-TC
- ↑ Circumcision. Daecher M. Icon 1998;2(2):70-3.
- ↑
Pitta J: Biosynthetics. Forbes. Pp. 170-1.
Note: The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin." - ↑
Hall CT. Biotech's Big Discovery. San Francisco Chronicle. 25 October 1996; : E1+E4.
